
Medeloop
An AI-driven platform for conducting early-stage clinical research and trials, simplifying grant applications, data collection, harmonization, biomarker identification, and manuscript submissions.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor investor investor investor investor | €0.0 | round | |
* | $15.5m | Series A | |
Total Funding | 000k |
Related Content
Medeloop is an AI-driven platform designed to accelerate clinical and public health research. The platform serves researchers, pharmaceutical companies, and healthcare providers by streamlining the entire research process, from generating hypotheses and securing funding to managing studies and analyzing data. Medeloop's business model is centered on providing access to its comprehensive suite of AI tools that automate and enhance various aspects of medical research. The company generates revenue through subscriptions to its platform, which offers features like two-way messaging for patient-care team interaction, advanced data analytics for identifying biomarkers and drug targets, and tools for grant writing and scientific publication. By integrating and harmonizing extensive health data, Medeloop aims to significantly expedite the discovery of new treatments and improve patient outcomes. The company operates in the health-tech market, with a focus on early-stage clinical research and trials.
Keywords: clinical research, public health, AI-driven platform, data analysis, drug discovery, healthcare management, patient communication, grant writing, scientific publication, biomarkers